# reload+after+2024-01-19 22:47:07.757545
address1§2400 District Avenue
address2§Suite 310
city§Burlington
state§MA
zip§01803
country§United States
phone§617 517 0730
website§https://www.scpharmaceuticals.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
fullTimeEmployees§96
companyOfficers§[{'maxAge': 1, 'name': 'Mr. John H. Tucker', 'age': 60, 'title': 'President, CEO, Principal Executive Officer & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 912202, 'exercisedValue': 0, 'unexercisedValue': 2132407}, {'maxAge': 1, 'name': 'Ms. Rachael  Nokes', 'age': 48, 'title': 'CFO & Principal Accounting Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 496454, 'exercisedValue': 0, 'unexercisedValue': 157581}, {'maxAge': 1, 'name': 'Mr. Michael D. Hassman', 'title': 'Senior Vice President of Technical Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Katherine  Taudvin', 'title': 'Vice President of Corporate Affairs & Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. John  Mohr Pharm.D.', 'title': 'Senior Vice President of Clinical Development & Medical Affairs', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Steve  Parsons', 'title': 'Senior Vice President of Commercial', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§5
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§6
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.014
priceToSalesTrailing12Months§30.37404
currency§USD
dateShortInterest§1702598400
forwardEps§-1.19
exchange§NMS
quoteType§EQUITY
shortName§scPharmaceuticals Inc.
longName§scPharmaceuticals Inc.
firstTradeDateEpochUtc§1510929000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2d6ad3bd-3b62-3f1a-a763-1fac3c38cb85
gmtOffSetMilliseconds§-18000000
targetHighPrice§25.0
targetLowPrice§16.0
targetMeanPrice§18.67
targetMedianPrice§17.5
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§6
quickRatio§8.733
grossMargins§0.72816
ebitdaMargins§0.0
trailingPegRatio§None
